Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 27

1.

Hydrogel microstructure live-cell array for multiplexed analyses of cancer stem cells, tumor heterogeneity and differential drug response at single-element resolution.

Afrimzon E, Botchkina G, Zurgil N, Shafran Y, Sobolev M, Moshkov S, Ravid-Hermesh O, Ojima I, Deutsch M.

Lab Chip. 2016 Mar 21;16(6):1047-62. doi: 10.1039/c6lc00014b. Epub 2016 Feb 23.

PMID:
26907542
2.

Establishment of highly tumorigenic human colorectal cancer cell line (CR4) with properties of putative cancer stem cells.

Rowehl RA, Burke S, Bialkowska AB, Pettet DW 3rd, Rowehl L, Li E, Antoniou E, Zhang Y, Bergamaschi R, Shroyer KR, Ojima I, Botchkina GI.

PLoS One. 2014 Jun 12;9(6):e99091. doi: 10.1371/journal.pone.0099091. eCollection 2014.

3.

Prostate cancer stem cell-targeted efficacy of a new-generation taxoid, SBT-1214 and novel polyenolic zinc-binding curcuminoid, CMC2.24.

Botchkina GI, Zuniga ES, Rowehl RH, Park R, Bhalla R, Bialkowska AB, Johnson F, Golub LM, Zhang Y, Ojima I, Shroyer KR.

PLoS One. 2013 Sep 24;8(9):e69884. doi: 10.1371/journal.pone.0069884. eCollection 2013.

4.

Colon cancer stem cells--from basic to clinical application.

Botchkina G.

Cancer Lett. 2013 Sep 10;338(1):127-40. doi: 10.1016/j.canlet.2012.04.006. Epub 2012 Apr 23. Review.

PMID:
22537805
5.

New-generation taxoid SB-T-1214 inhibits stem cell-related gene expression in 3D cancer spheroids induced by purified colon tumor-initiating cells.

Botchkina GI, Zuniga ES, Das M, Wang Y, Wang H, Zhu S, Savitt AG, Rowehl RA, Leyfman Y, Ju J, Shroyer K, Ojima I.

Mol Cancer. 2010 Jul 14;9:192. doi: 10.1186/1476-4598-9-192.

6.

Molecular mechanism of chemoresistance by miR-215 in osteosarcoma and colon cancer cells.

Song B, Wang Y, Titmus MA, Botchkina G, Formentini A, Kornmann M, Ju J.

Mol Cancer. 2010 Apr 30;9:96. doi: 10.1186/1476-4598-9-96.

7.

Mechanism of chemoresistance mediated by miR-140 in human osteosarcoma and colon cancer cells.

Song B, Wang Y, Xi Y, Kudo K, Bruheim S, Botchkina GI, Gavin E, Wan Y, Formentini A, Kornmann M, Fodstad O, Ju J.

Oncogene. 2009 Nov 19;28(46):4065-74. doi: 10.1038/onc.2009.274. Epub 2009 Sep 7.

8.

Phenotypic subpopulations of metastatic colon cancer stem cells: genomic analysis.

Botchkina IL, Rowehl RA, Rivadeneira DE, Karpeh MS Jr, Crawford H, Dufour A, Ju J, Wang Y, Leyfman Y, Botchkina GI.

Cancer Genomics Proteomics. 2009 Jan-Feb;6(1):19-29.

9.

Genomic analysis of prostate cancer stem cells isolated from a highly metastatic cell line.

Rowehl RA, Crawford H, Dufour A, Ju J, Botchkina GI.

Cancer Genomics Proteomics. 2008 Nov-Dec;5(6):301-10.

10.

Clinical significance of telomerase activity in peritoneal disseminated cells: gastrointestinal cancers.

Botchkina IL, Rivadeneira DE, Watkins K, Karpeh MS, Botchkina GI.

Mol Med. 2008 Jan-Feb;14(1-2):45-54.

11.

Highly sensitive revealing of PCR products with capillary electrophoresis based on single photon detection.

Kabotyanski EA, Botchkina IL, Kosobokova O, Botchkina GI, Gorfinkel V, Gorbovitski B.

Biosens Bioelectron. 2006 Apr 15;21(10):1924-31. Epub 2006 Mar 3.

PMID:
16516459
12.

Noninvasive detection of prostate cancer by quantitative analysis of telomerase activity.

Botchkina GI, Kim RH, Botchkina IL, Kirshenbaum A, Frischer Z, Adler HL.

Clin Cancer Res. 2005 May 1;11(9):3243-9.

13.

Inhibition of p38 mitogen activate kinase attenuates the severity of pancreatitis-induced adult respiratory distress syndrome.

Denham W, Yang J, Wang H, Botchkina G, Tracey KJ, Norman J.

Crit Care Med. 2000 Jul;28(7):2567-72.

PMID:
10921596
14.

Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin.

Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, Watkins LR, Wang H, Abumrad N, Eaton JW, Tracey KJ.

Nature. 2000 May 25;405(6785):458-62.

PMID:
10839541
15.

Evidence of a central role for p38 map kinase induction of tumor necrosis factor alpha in pancreatitis-associated pulmonary injury.

Yang J, Murphy C, Denham W, Botchkina G, Tracey KJ, Norman J.

Surgery. 1999 Aug;126(2):216-22.

PMID:
10455887
16.

Loss of NF-kappaB activity during cerebral ischemia and TNF cytotoxicity.

Botchkina GI, Geimonen E, Bilof ML, Villarreal O, Tracey KJ.

Mol Med. 1999 Jun;5(6):372-81.

17.

Cerebral ischemia enhances polyamine oxidation: identification of enzymatically formed 3-aminopropanal as an endogenous mediator of neuronal and glial cell death.

Ivanova S, Botchkina GI, Al-Abed Y, Meistrell M 3rd, Batliwalla F, Dubinsky JM, Iadecola C, Wang H, Gregersen PK, Eaton JW, Tracey KJ.

J Exp Med. 1998 Jul 20;188(2):327-40.

18.

The tetravalent guanylhydrazone CNI-1493 blocks the toxic effects of interleukin-2 without diminishing antitumor efficacy.

Kemeny MM, Botchkina GI, Ochani M, Bianchi M, Urmacher C, Tracey KJ.

Proc Natl Acad Sci U S A. 1998 Apr 14;95(8):4561-6.

19.

Expression of TNF and TNF receptors (p55 and p75) in the rat brain after focal cerebral ischemia.

Botchkina GI, Meistrell ME 3rd, Botchkina IL, Tracey KJ.

Mol Med. 1997 Nov;3(11):765-81.

20.

Tumor necrosis factor is a brain damaging cytokine in cerebral ischemia.

Meistrell ME 3rd, Botchkina GI, Wang H, Di Santo E, Cockroft KM, Bloom O, Vishnubhakat JM, Ghezzi P, Tracey KJ.

Shock. 1997 Nov;8(5):341-8.

PMID:
9361344
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk